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Abstract
Á-Secretase is a high-molecular-weight protein complex
required for the proteolytic processing of various trans-
membrane proteins including the Alzheimer’s disease-
associated amyloid precursor protein and the signaling
receptor Notch. One of the Á-secretase complex compo-
nents is the type I transmembrane protein nicastrin. Here
we review the odyssey to a cyclopic fish, which at the
end allowed the functional analysis of nicalin, a novel
member of the nicastrin protein family. This 60-kDa pro-
tein is part of a previously unknown membrane protein
complex unrelated to Á-secretase and binds to Nomo
(Nodal modulator, previously known as pM5), a novel
130-kDa transmembrane protein. Both proteins are high-
ly conserved in metazoans and show almost identical tis-
sue distribution in humans. Functional studies in zebra-
fish embryos and cultured human cells revealed that
nicalin and Nomo collaborate to antagonize the Nodal/
TGFß signaling pathway. Thus, nicastrin and nicalin are
both associated with protein complexes involved in cell
fate decisions during early embryonic development.
Copyright © 2004 S. Karger AG, Basel
The Á-secretase cleavage is the final step in the proteo-
lytic processing of various type I transmembrane proteins
that have undergone ectodomain shedding, most impor-
tantly the amyloid precursor protein (APP) and the signal-
ing receptor Notch [1, 2]. Processing of APP leads to the
generation of the amyloid-ß peptide, which is deposited in
brains of Alzheimer’s disease patients [3, 4]. The cleavage
of Notch is required for the activation of the Notch signal-
ing pathway, which mediates cell fate decisions at various
stages during embryonic development [5, 6]. The Á-secre-
tase cleavage is unusual, since it occurs within the hydro-
phobic environment of the membrane and is mediated by
a high-molecular-weight protein complex consisting of
presenilins, nicastrin, APH-1 and PEN-2 [7, 8] (fig. 1a).
The presenilins are polytopic transmembrane proteases
which provide the active site of the Á-secretase complex
[9]. The type I transmembrane protein nicastrin interacts
with presenilins [10] and APH-1 [11] and is required for
the assembly and stabilization of the complex. Its large
extracytosolic domain contains a F200-amino acid re-
gion which is predicted to adopt a fold similar to the ami-
nopeptidase domain found in several aminopeptidases
and the transferrin receptors [12]. The integrity of the
aminopeptidase domain of nicastrin is necessary for Á-
secretase activity [10, 13] and the maturation of the Á-
secretase complex is accompanied by a change in the
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Fig. 1. Nicalin is a nicastrin-related protein.
a Intramembrane proteolysis of APP by the
Á-secretase complex. APP is first cleaved by
ß-secretase (arrowhead) to generate C99, the
substrate for Á-secretase. C99 then enters the
Á-secretase complex (gray box) which con-
sists of presenilins (PS), nicastrin, PEN-2
and APH-1. The two critical aspartates in
the transmembrane domains 6 and 7 of PS
N-terminal (NTF) and C-terminal (CTF)
fragments mediate endoproteolysis of C99
resulting in the secretion of amyloid-ß pep-
tide and the liberation of AICD (APP intra-
cellular domain). b Phylogenetic tree show-
ing that the nicalins are more closely related
to nicastrins than to transferrin receptors
and active aminopeptidases. NAALADL =
N-Acetyl-·-linked acidic dipeptidase-like
protein; PSMA = prostate-specific mem-
brane antigen; TFR = transferrin receptor;
NCL = nicalin; NCT = nicastrin; HS =
Homo sapiens; RN = Rattus novegicus;
MM = Mus musculus; DM = Drosophila me-
lanogaster; CE = Caenorhabditis elegans;
AT = Arabidopsis thaliana.
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structure of nicastrin [13]. Since none of the Á-secretase
complex components can act by themselves, the identifi-
cation of the individual functions of the components is
extraordinarily difficult.
In an attempt to gain further insight into the mode of
action of nicastrin, we searched for nicastrin-related pro-
teins by scanning protein and genome databases with gen-
eralized profiles constructed from the ectodomain of the
nicastrin family [14]. This search identified a novel puta-
tive transmembrane protein with the same phyletic distri-
bution as nicastrin (fig. 1b). Since this protein is predicted
to represent a type I transmembrane protein with the
same overall architecture as nicastrin, we refer to it as
nicalin (nicastrin-like protein). The sequence similarity is
confined to a region of 180 residues, which roughly corre-
sponds to the previously described aminopeptidase do-
main. Analysis of nicalin by blue-native polyacrylamide
gel electrophoresis revealed its presence in a high-molecu-
lar-weight membrane protein complex with a size surpris-
ingly similar to Á-secretase (fig. 2a). However, in nicalin
immunoprecipitates, Á-secretase components were not
detected demonstrating that that these complexes are
completely unrelated [14]. Instead, a 130-kDa protein
coprecipitated with nicalin (fig. 2b) which was identified
by mass spectrometry as pM5, a protein of unknown func-
tion. Based on the results of our analysis in zebrafish
embryos (see below), we refer to it as Nomo (Nodal modu-
lator). The significance of the nicalin/Nomo interaction
is further underscored by the following observations:
(1) orthologs of both proteins can be found in invertebrates
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Fig. 2. The nicalin/Nomo complex is in-
volved in cell fate decisions during zebrafish
embryogenesis. a Immunoblot of blue-na-
tive gels of membrane protein extracts from
HEK293 cells expressing the APP Swedish
mutant (Sw) and nicalin (Sw/Ncl). Nicalin
immunoreactivity is seen in a high-molecu-
lar-weight complex with a size similar to Á-
secretase, which is detected with an anti-pre-
senilin 1 antibody (·-PS1). b Coomassie-
stained SDS gel containing proteins immu-
noprecipitated with ·-nicalin antibodies
from Sw or Sw/Ncl cell membrane prepara-
tions. A 60- and a 130-kDa band were specif-
ically enriched in precipitates from Sw/Ncl
cells (* = immunoglobulin heavy chain).
Peptide mass fingerprints generated by
MALDI analysis identified these bands as
nicalin and pM5, which we refer to as Nomo.
c Coexpression of ncl1 and nomo in zebra-
fish embryos affects cell fate decisions lead-
ing to cyclopia. 36 h postfertilization mor-
phology of a wild-type embryo (top panel)
and an embryo coinjected with ncl1 and
nomo capped RNAs (bottom panel). Note
the prominent cyclopia of the injected em-
bryo (arrow).
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Fig. 3. Model of the inhibition of Nodal/TGFß signaling by the nica-
lin/Nomo complex. TGFß ligands act via dimeric kinase receptors
(ActRIIB and ALK4) which activate signal transducers of the Smad
family [19]. In the nucleus, protein complexes containing Smad pro-
teins and transcription factors are formed which activate the tran-
scription of target genes. The binding of Nodal (but not TGFß or
activin) to its receptor requires a coreceptor of the EGF-CFC family
(Oep/Cripto). The specific Nodal inhibitor Lefty acts by inactivating
Oep/Cripto (or Nodal itself). In contrast, the nicalin/Nomo complex
appears to antagonize Nodal/TGFß signaling at a more downstream
step. Oep = One-eyed pinhead; ActRIIB = activin-type receptor IIB;
Alk4 = activin receptor-like kinase 4; FoxHI/FAST2 = forkhead tran-
scription factor.
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and plants (fig. 1b), (2) their tissue distribution is highly
similar in humans [14] and (3) both nicalin and Nomo
localize to the endoplasmic reticulum (unpubl. data).
To identify the biological function of this novel protein
complex, we used the zebrafish system which has been
successfully used to recapitulate the defects in somite for-
mation associated with the inhibition of Notch signaling
[15]. One Nomo (nomo) and two nicalin orthologs (ncl1,
ncl2) were found in the zebrafish genome. Interfering
with nomo and/or ncl1 expression levels in zebrafish
embryos failed to produce phenotypes related to Notch
signaling deficiencies, pointing to the distinct functions of
the Á-secretase and the nicalin/Nomo complex in vivo
[14]. In contrast, we found that ectopic coexpression of
Nomo and Ncl1, but not of each factor alone, led to
cyclopic, ‘squint-eyed’ embryos (fig. 2c). Blocking the pro-
duction of Nomo with an antisense oligonucleotide re-
sulted in the development of a massively enlarged hatch-
ing gland [14]. Both phenotypes can arise through a fail-
ure in the proper patterning of embryonic mesendoder-
mal tissue [16, 17], a process regulated by the TGFß factor
Nodal [18]. In situ hybridization experiments indeed
demonstrated that downregulation of Nomo increased the
amount of anterior axial mesendoderm indicating en-
hanced Nodal signaling [14]. These data pointed to an
antagonistic role of the nicalin/Nomo complex in the
Nodal pathway and were confirmed by the finding that
enhanced inhibition of Nodal signaling by the overexpres-
sion of the specific Nodal inhibitor Lefty was counter-
acted by blocking Nomo expression [14]. To analyze if
nicalin and Nomo affect Nodal signaling directly, a luci-
ferase reporter assay in human embryonic kidney 293T
cells was established. Overexpression of nicalin or Nomo
in these cells dose-dependently reduced luciferase activity
derived from a TGFß-responsive promoter [14]. We,
thus, propose a direct role for the nicalin/Nomo complex
in the modulation of Nodal/TGFß signaling (fig. 3).
Taken together these recent findings suggest that pro-
teins of the nicastrin family may have evolved to fulfill
biological functions in cell fate decisions during early
embryogenesis. Interestingly, the function of these pro-
teins in Notch and Nodal signaling is associated with a
high-molecular-weight protein complex.
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